000 | 00964 a2200253 4500 | ||
---|---|---|---|
005 | 20250517191132.0 | ||
264 | 0 | _c20190313 | |
008 | 201903s 0 0 eng d | ||
022 | _a1471-4973 | ||
024 | 7 |
_a10.1016/j.coph.2017.11.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBewick, Gavin A | |
245 | 0 | 0 |
_aEditorial overview: Endocrine and metabolic diseases: Busting BMI: new strategies for the treatment of obesity and metabolic disease. _h[electronic resource] |
260 |
_bCurrent opinion in pharmacology _c12 2017 |
||
300 |
_aix-xii p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 |
_aEndocrine Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMetabolic Diseases _xdrug therapy |
650 | 0 | 4 |
_aObesity _xdrug therapy |
773 | 0 |
_tCurrent opinion in pharmacology _gvol. 37 _gp. ix-xii |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.coph.2017.11.012 _zAvailable from publisher's website |
999 |
_c27873504 _d27873504 |